No Data
No Data
Barclays Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $263
Barclays analyst Stephanie Davis maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $263.According to TipRanks data, the analyst has a success rate of 42.1% and a total
Barclays Sticks to Its Buy Rating for Cencora (COR)
Cencora (NYSE:COR) Ticks All The Boxes When It Comes To Earnings Growth
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit.
Citi Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $280
Citi analyst Daniel Grosslight maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $280.According to TipRanks data, the analyst has a success rate of 50.4% and a total
Insider Sale: Steven Collis Sells 10,755 Shares of Cencora Inc (COR)
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report